I am originally from Querétaro, Mexico, where I studied a BSc in Microbiology at the Autonomous University of Querétaro. Having mostly trained in molecular biology techniques, I became interested in the dry-lab aspect of biology by the end of my undergraduate studies. Seeking opportunities to train in bioinformatics, I joined the Cancer Genetics and Bioinformatics Laboratory at the National Autonomous University of Mexico, where I became fascinated by the power of high-throughput genomic assays to understand cellular phenotypes and, ultimately, health and disease states. I pursued further training at the Wellcome Sanger Institute, where I completed a one-year MPhil mapping GWAS variants to transient cell types and states generated during early embryonic development. Having enjoyed my experience at Sanger, I then joined its four-year PhD programme, where I studied different aspects of mutation in human germline tissue. Having completed my graduate studies, I continue to seek a deeper understanding of the molecular basis of complex traits, taking advantage of the rapidly expanding landscape of multi-omics tools. As a postdoctoral fellow in the Anderson team, I will investigate how proteogenomic signatures are associated with treatment outcomes in a cohort of approximately 1,500 participants from the IBD Response project. Outside of the lab, I enjoy cycling, photography, and videogames.
